287
Participants
Start Date
April 30, 2010
Primary Completion Date
May 31, 2011
Study Completion Date
May 31, 2011
Probuphine (buprenorphine implant)
Implantable formulation of buprenorphine made of buprenorphine HCl/ethylene vinyl acetate, considered a drug.
placebo implant
Implant contains ethylene vinyl acetate
Buprenorphine
sublingual buprenorphine/naloxone tablets
New York VA Medical Center, NYU School of Medicine, New York
St. Luke's Roosevelt Hospital Center, New York
University of Pennsylvania, Philadelphia
BPRU, Behavioral Biology Research Center, Baltimore
Duke University, Duke Addictions Program, Durham
Carolina Clinical Trials, Inc., Charleston
Amit Vijapura, MD, Jacksonville
Scientific Clinical Research, Inc., North Miami
Fidelity Clinical Research, Inc., Lauderhill
Operation PAR, Inc. - TC Campus, Largo
Precise Research Centers, Flowood
University of Cincinnati, Cincinnati
PsychCare Consultants Research, St Louis
David Geffen School of Medicine at UCLA, Los Angeles
Friends Research Institute, Torrance
Synergy Clinical Research Center, National City
North County Clinical Research, Oceanside
Providence Behavioral Health Services, Everett
SSTAR: Stanley Street Treatment and Resources, Inc., Fall River
University of Vermont, Burlington
Lead Sponsor
National Institute on Drug Abuse (NIDA)
NIH
Titan Pharmaceuticals
INDUSTRY